30 Day Trial

Vericel Posts MACI 1Q18 Revenue Growth

Share:

For 1Q18, Vericel posted orthobiologic revenue of US $12.1MM, +142% vs. 1Q17.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.